ASHG Annual Meeting 2025

Join us at ASHG 2025 to explore how Illumina is shaping the next wave of biology. Discover our latest innovations in sequencing, informatics, array, and library prep solutions designed to deliver multidimensional insights at scale. From scalable single-omic to fully connected multiomic workflows, Illumina empowers researchers to unlock every assay, every variant, every layer of biology from genome to proteome. Whether you're advancing population-scale studies or resolving biology at the single-cell level, come see how Illumina can partner with you to accelerate discovery, redefine standards, and maximize impact.

Visit Illumina booth 1019 to explore our latest products, workflow innovations, and strategic partnerships. Join our Industry Education sessions and Co-Labs to see how we’re advancing the future of genomics.

Industry Education sessions

Redefining the limits of what’s possible: Sequencing reimagined

Wednesday, October 15
12 noon–1 PM (ET)
Room 153 ABC

Register now

• Steve Barnard, PhD, Chief Technology Officer, Illumina
• Joe Devaney, PhD, Director of Laboratory Innovation Team, GeneDx
• Bekim Sadikovic, PhD, Director of the Molecular Genetics Laboratory at London Health Sciences Centre Research Institute

Beyond the genome with multiomics: Unlocking deeper biology

Thursday, October 16
12 noon–1PM (ET)
Room 154

• Cande Rogert, PhD, VP, Global Head of Advanced Science, Illumina
• Brendan Keating, PhD, Associate Professor, Division of Transplantation, Dept of Surgery, and Institute of Systems Genetics, NYU Langone Health
• Matthew Brown, PhD, Chief Scientific Officer, Genomics England, Professor of Medicine, King’s College London
• Sheila Dodge, MLA, MBA, Chief Operating Officer, Broad Clinical Labs; Sr. Director, Strategic Financial Operations, Platforms; Institute Scientist, The Broad

Igniting translational breakthroughs: How scalable informatics, AI, and Perturb-seq are transforming human genetics

Thursday, October 16
3 PM–4 PM (ET)
Room 151A

• Rami Mehio, VP, Head of Global Software and Informatics, Illumina
• Kyle Farh, MD, PhD, VP & Distinguished Scientist, Illumina Artificial Intelligence Lab, Illumina

CoLab session

Recent advances in methylation-informed cell deconvolution

Thursday, October 16
10:15 AM–10:45 AM (ET)
CoLab Theater 1

• Lucas Salas, MD, PhD, MPH, Asst Professor of Epidemiology, Geisel School of Medicine, Dartmouth College

Main session talks

The impact of rare deleterious mutations on human lifespan

Friday, October 17
5 PM–6:30 PM (ET)

• Kyle Farh, MD, PhD, VP & Distinguished Scientist, Illumina Artificial Intelligence Lab, Illumina

Predicting deleterious promoter mutations with deep learning

Friday, October 17
8:30 AM–10 AM (ET)

• Kishore Jaganathan, PhD, Director, Deep Learning, Illumina

MicroRNA Perturb-seq reveals genome-wide functional targets and deleterious 3' UTR variants

Thursday, October 16
1:30 PM–2:30 PM (ET)

• Eyal Ben David, PhD, Sr Manager, Bioinformatics, Illumina